Anisodamine hydrobromide in the treatment of critically ill patients with septic shock: a multicenter randomized controlled trial
Fang Zhang,Xue Mei,Ping Zhou,Ying-Ping Tian,Jin-Xiang Liu,Xu Dong,Ding-Shan Yuan,Zhao-Fen Lin,Lei Zhang,Jin-Hao Lin,Ai-Jun Li,Xing Deng,Ming-Zhi Chen,Shi-Ying Yuan,Jun-Jing Zha,Bin Shi,Zhi-Hong Lin,Shu-Bin Guo,Fang ZhangXue MeiPing ZhouYing-Ping TianJin-Xiang LiuXu DongDing-Shan YuanZhao-Fen LinLei ZhangJin-Hao LinAi-Jun LiXing DengMing-Zhi ChenShi-Ying YuanJun-Jing ZhaBin ShiZhi-Hong LinShu-Bin Guoa Beijing Chao-Yang Hospital,Capital Medical University,Beijing,Chinab Sichuan Provincial People's Hospital,Chengdu,Chinac Second Hospital of Hebei Medical University,Shijiazhuang,Chinad Second Nanning People's Hospital,Nanning,Chinae Hebei Provincial Hospital of Chinese Medicine,Shijiazhuang,Chinaf Affiliated Hospital of Nantong University,Nantong,Chinag Shanghai Changzheng Hospital,Shanghai,Chinah Tongji Hospital of Tongji University,Wuhan,Chinai Longyan People's Hospital of Fujian,Longyan,Chinaj Handan Central Hospital,Handan,Chinak Second Hospital of Longyan,Longyan,Chinal Jinjiang Hospital,Jinjiang,Chinam Wuhan Union Hospital,Wuhan,Chinan Anqing Municipal Hospital,Anqing,Chinao Yangpu Hospital of Tongji University,Shanghai,Chinap First Affiliated Hospital of Fujian Medical University,Fuzhou,China
DOI: https://doi.org/10.1080/07853890.2023.2264318
IF: 5.348
2023-10-05
Annals of Medicine
Abstract:Background Septic shock is the development of sepsis to refractory circulatory collapse and metabolic derangements, characterized by persistent hypotension and increased lactate levels. Anisodamine hydrobromide (Ani HBr) is a Chinese medicine used to improve blood flow in circulatory disorders. The purpose of this study was to determine the therapeutic efficacy of Ani HBr in the treatment of patients with septic shock.
medicine, general & internal